+44 (0)20 3910 4640 info@symmetron.net
  • 🗨 We’re hiring!
Symmetron
  • Services
  • Therapeutic areas
  • The Team
  • Careers
  • Contact
Select Page

Economic evaluation of insertable cardiac monitors in detecting previously undiagnosed atrial fibrillation and subsequently moderating stoke risk in a high-risk population in the United Kingdom

by Symmetron | Jan 19, 2019

atrial fibrillation   Economic evaluation of insertable cardiac monitors in detecting previously undiagnosed atrial fibrillation and subsequently moderating stoke risk in a high-risk population in the United Kingdom Presented at ESC Congress. August 25-29, 2018....

Economic evaluation of insertable cardiac monitors to detect atrial fibrillation and subsequently moderate stroke risk in a high-risk population in the UK

by Symmetron | Jan 18, 2019

atrial fibrillation Economic evaluation of insertable cardiac monitors to detect atrial fibrillation and subsequently moderate stroke risk in a high-risk population in the UK Presented at ISPOR Europe.  November 10-14, 2018. Barcelona, Spain. Authors C. Rinciog, L....

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke

by Symmetron | Jan 18, 2019

atrial fibrillation   Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. (UK) International Journal of Stroke. 2016;11(3):302-12 Authors Diamantopoulos A, Sawyer LM, Lip GY, Witte KK, Reynolds MR,...

Recent Comments

    Archives

    Categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Privacy Policy
    © 2019 Symmetron Ltd